Rodents present low basal PPAR-α expression and moderate PPAR-β/δ expression in WAT [23–25] and their pharmacological induction has been regarded as promising tools to tackle metabolic constraints stemmed from obesity [25]. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.